GenHealth.ai
Use Cases
Products
Company
Research
Get a Demo
See how we Automate Prior Authorization
Use our Population Health Analytics Co-pilot
Search all medical codes
Z51.11
Encounter for antineoplastic chemotherapy
ICD10CM code
Medical Policies and Guidelines for Encounter for antineoplastic chemotherapy
Related policies from health plans
ANTHEM-BLUECROSS-CA
Adstiladrin (nadofaragene firadenovec-vncg)
ANTHEM-BLUECROSS-CA
Adstiladrin (nadofaragene firadenovec-vncg)
ANTHEM-BLUECROSS-CA
Akynzeo (fosnetupitant and palonosetron) for injection
ANTHEM-BLUECROSS-CA
Akynzeo (fosnetupitant and palonosetron) for injection
ANTHEM-BLUECROSS-CA
Bevacizumab for Non-Ophthalmologic Indications
ANTHEM-BLUECROSS-CA
Darzalex (daratumumab)
ANTHEM-BLUECROSS-CA
Denosumab agents
ANTHEM-BLUECROSS-CA
Elzonris (tagraxofusp-erzs)
ANTHEM-BLUECROSS-CA
Erbitux (cetuximab)
ANTHEM-BLUECROSS-CA
Kadcyla (ado-trastuzumab)
ANTHEM-BLUECROSS-CA
Selected Injectable 5HT3 Antiemetic Agents
ANTHEM-BLUECROSS-CA
Thyroid Testing
ANTHEM-BLUECROSS-CA
Vectibix (panitumumab)
CIGNA
Low-Level Laser and High-Power Laser Therapy - (CPG030)
ANTHEM-BLUECROSS-CT
CG-LAB-20 Thyroid Testing
CIGNA
Transthoracic Echocardiography in Adults - (0510)
CIGNA
Transthoracic Echocardiography in Adults - (0510)
CIGNA
Transthoracic Echocardiography in Children - (0523)
CIGNA
Transthoracic Echocardiography in Children - (0523)
ANTHEM-BLUECROSS-CT
MED.00128 Insulin Potentiation Therapy
Similar Codes
ICD10CM codes
Z51.11
- Encounter for antineoplastic chemotherapy
Z51.1
- Encounter for antineoplastic chemotherapy and immunotherapy
Z51.0
- Encounter for antineoplastic radiation therapy
Z51.12
- Encounter for antineoplastic immunotherapy
Z92.21
- Personal history of antineoplastic chemotherapy
D64.81
- Anemia due to antineoplastic chemotherapy
Z92.6
- Personal history of chemotherapy for neoplastic disease
T80.810A
- Extravasation of vesicant antineoplastic chemotherapy, initial encounter
T80.810
- Extravasation of vesicant antineoplastic chemotherapy
T80.810D
- Extravasation of vesicant antineoplastic chemotherapy, subsequent encounter
HCPCS codes
J9999
- Not otherwise classified, antineoplastic drugs
G8927
- Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer
G9842
- Patient has metastatic disease at diagnosis
J8999
- Prescription drug, oral, chemotherapeutic, nos
J9351
- Injection, topotecan, 0.1 mg
S9329
- Home infusion therapy, chemotherapy infusion; administrative services, professional pharmacy service
J9000
- Injection, doxorubicin hydrochloride, 10 mg
Q2050
- Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg
S9359
- Home infusion therapy, anti-tumor necrosis factor intravenous therapy; (e.g., infliximab); administr
S9331
- Home infusion therapy, intermittent (less than twenty-four hours) chemotherapy infusion; administrat
CPT4 codes
96402
- Chemotherapy administration, subcutaneous or intramuscular; hormonal anti-neoplastic
96401
- Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic
96549
- Unlisted chemotherapy procedure
96406
- Chemotherapy administration; intralesional, more than 7 lesions
96405
- Chemotherapy administration; intralesional, up to and including 7 lesions
96411
- Chemotherapy administration; intravenous, push technique, each additional substance/drug (List separ
96415
- Chemotherapy administration, intravenous infusion technique; each additional hour (List separately i
96409
- Chemotherapy administration; intravenous, push technique, single or initial substance/drug
96440
- Chemotherapy administration into pleural cavity, requiring and including thoracentesis
88239
- Tissue culture for neoplastic disorders; solid tumor
Choose how you'd like to learn more
Email
Send us a message or questions and we can share more details.
Name
Email
Message
Company Name
Submit
Meet
Setup a calendar meeting with us; find a time now.
DIY Demo
Sign up for a free account to see our product in action.
Demo Gen AI Healthcare Analytics